Please login to the form below

Not currently logged in
Email:
Password:

Nuclear medicine

This page shows the latest Nuclear medicine news and features for those working in and with pharma, biotech and healthcare.

Coronavirus disruption scuppers Curium Pharma sale

Coronavirus disruption scuppers Curium Pharma sale

The impact of coronavirus on the economy took another turn this week after CapVest shelved its sale of nuclear medicine specialist Curium Pharma, blaming the outbreak. ... Paris-headquartered Curium was formed three years ago via the merger of

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    Pharmaceutical companies are expanding into other non-medicine technologies in addition to digital technology. ... Mallinckrodt (US) Nuclear Imaging business. IBA Molecular (BE). Asset acquisition. Diagnostic imaging products for use in nuclear medicine

  • Deal Watch March 2016 Deal Watch March 2016

    Portfolio of diagnostic equipment including X-ray, MRI, Ultrasound and Nuclear Medicine systems.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics